Clinical Report: Benefits of Enhanced Recovery Protocols in Robotic Nephrectomy
Overview
Implementation of an Enhanced Recovery After Surgery (ERAS) pathway in robotic nephrectomy significantly reduced hospital length of stay and opioid use without increasing complications or readmissions. ERAS protocols facilitated faster return to oral intake and bowel function compared to traditional care.
Background
Enhanced Recovery After Surgery (ERAS) is a multidisciplinary, evidence-based perioperative care approach designed to reduce surgical stress and improve recovery. While ERAS has demonstrated benefits in various urologic surgeries, its impact on robotic nephrectomy patients remains underexplored. Robotic nephrectomy, increasingly common for renal pathology, typically results in shorter hospital stays than open surgery, but patients still face barriers to discharge such as pain and gut dysfunction. This study evaluates the effects of a standardized ERAS pathway on perioperative outcomes in robotic nephrectomy.
Data Highlights
Outcome
Traditional Care
ERAS Pathway
Statistical Significance
Hospital Length of Stay (days)
Median not specified
Significantly reduced
p < 0.05
Postoperative Opioid Use (oral morphine equivalents, 48h)
Higher
Lower
p < 0.05
Time to Oral Liquid Intake
Longer
Shorter
p < 0.05
Time to Solid Food Intake
Longer
Shorter
p < 0.05
Time to Flatus
Longer
Shorter
p < 0.05
30-day Readmission Rate
No significant difference
No significant difference
NS
Surgical Site Infection Rate
No significant difference
No significant difference
NS
Postoperative Complications
No significant difference
No significant difference
NS
Total Hospital Costs
Not specified
Not specified
Not specified
Key Findings
ERAS implementation significantly reduced hospital length of stay in robotic nephrectomy patients.
Postoperative opioid requirements within 48 hours were significantly lower in the ERAS group.
Patients on ERAS pathways resumed oral liquid and solid food intake earlier than those receiving traditional care.
Time to first flatus, indicating return of bowel function, was shorter with ERAS protocols.
No increase in 30-day readmission rates, surgical site infections, or postoperative complications was observed with ERAS.
ERAS pathways standardized perioperative care through a multidisciplinary approach, improving recovery metrics without added risk.
Clinical Implications
Adopting ERAS protocols for robotic nephrectomy can enhance patient recovery by reducing hospital stay and opioid consumption while promoting earlier return of gastrointestinal function. These benefits occur without increasing complication or readmission rates, supporting ERAS as a safe and effective standard of care. Multidisciplinary coordination is essential to successfully implement these pathways.
Conclusion
The study demonstrates that a comprehensive ERAS pathway improves perioperative outcomes in robotic nephrectomy, facilitating faster recovery and reduced opioid use without compromising patient safety. ERAS should be considered a standard approach in robotic nephrectomy care.
References
Enhanced Recovery After Surgery (ERAS) Society -- ERAS Protocols Overview
Urology Literature -- ERAS Benefits in Radical Cystectomy
Studies on Minimally Invasive Urologic Surgeries and ERAS
ERAS in Living Donor Nephrectomy -- Reduced LOS and Opioid Use
Indiana University Medical Center IRB No.10768 -- Robotic Nephrectomy ERAS Study
by William Pierre Schrock, Jason M. Farrow, Kevin M. Backfish-White, Amanda Marinho Lima, Sydney Elizabeth Strup, Jiangqiong Li, Chandru Sundaram, Amy L. McCutchan
